TRPC3/TRPC6 blockers (GlaxoSmith Kline)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTRPC3/TRPC6 blockers (GlaxoSmith Kline)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionShort transient receptor potential channel 3 antagonistsShort transient receptor potential channel 6 inhibitors
TargetsShort transient receptor potential channel 3Short transient receptor potential channel 6
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A